References

Export 2836 results:
Author Title Type [ Year(Asc)]
Submitted
Submitted.
2017
S. A. Freitas, MacKenzie, R., Wylde, D. N., Roudebush, B. T., Bergstrom, R. L., J Holowaty, C., Hart, A., Rigatti, S. J., and Gill, S., All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer., J Insur Med, vol. 47, no. 1, pp. 6-22, 2017.
T. Meagher and Trop, I., Breast Microcalcifications and Their Implications for Risk Assessment. A Brief Review., J Insur Med, vol. 47, no. 1, pp. 40-42, 2017.
B. Sagar, Lin, Y. Shen, and Castel, L. D., Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective., J Med Econ, vol. 20, no. 10, pp. 1018-1023, 2017.
T. Oka, Enoki, H., Tokimoto, Y., Kawanishi, T., Minami, M., Okuizumi, T., and Katahira, K., Employment-related difficulties and distressed living condition in patients with hepatitis B virus: A qualitative and quantitative study., BMC Public Health, vol. 17, no. 1, p. 568, 2017.
R. MacKenzie, A "Full Monty" Issue of the Journal., J Insur Med, vol. 47, no. 1, pp. 3-5, 2017.
S. Mohammed, Lim, Z., Dean, P. H., Potts, J. E., Tang, J. N. C., Etheridge, S. P., Lara, A., Husband, P., Sherwin, E. D., Ackerman, M. J., and Sanatani, S., Genetic Insurance Discrimination in Sudden Arrhythmia Death Syndromes: Empirical Evidence From a Cross-Sectional Survey in North America., Circ Cardiovasc Genet, vol. 10, no. 1, 2017.
A. J. Newson, Tiller, J., Keogh, L. A., Otlowski, M., and Lacaze, P., Genetics and Insurance in Australia: Concerns around a Self-Regulated Industry., Public Health Genomics, vol. 20, no. 4, pp. 247-256, 2017.
R. MacKenzie, Infarction or Pseudo-infarction?, J Insur Med, vol. 47, no. 1, pp. 50-54, 2017.
M. C. van Maaren, Bretveld, R. W., Jobsen, J. J., Veenstra, R. K., Groothuis-Oudshoorn, C. Gm, Struikmans, H., Maduro, J. H., Strobbe, L. Ja, Poortmans, P. Mp, and Siesling, S., The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival., Br J Cancer, vol. 117, no. 2, pp. 179-188, 2017.
JIM Reading List., J Insur Med, vol. 47, no. 1, pp. 58-62, 2017.
D. S. Williams, Kikuchi Disease., J Insur Med, vol. 47, no. 1, pp. 55-57, 2017.
F. Ahmadi, Park, J., Kim, K. Mee, and Ahmadi, N., Meaning-Making Coping Among Cancer Patients in Sweden and South Korea: A Comparative Perspective., J Relig Health, vol. 56, no. 5, pp. 1794-1811, 2017.
T. Meagher and Filzmaier, K., The Medical Underwriting of Transgender Individuals., J Insur Med, vol. 47, no. 1, pp. 43-49, 2017.
L. K. Tolusso, Collins, K., Zhang, X., Holle, J. R., C Valencia, A., and Myers, M. F., Pediatric Whole Exome Sequencing: an Assessment of Parents' Perceived and Actual Understanding., J Genet Couns, vol. 26, no. 4, pp. 792-805, 2017.
S. J. Rigatti, Random Forest., J Insur Med, vol. 47, no. 1, pp. 31-39, 2017.
D. Wesley, Regular Expressions: Mixed Effects Models., J Insur Med, vol. 47, no. 1, pp. 23-30, 2017.
C. Keppler, Plohmann, A. Maria, Pflueger, M., Rabovsky, K., Langewitz, W., and Mager, R., [Symptom Validation in Independent Medical Evaluations]., Fortschr Neurol Psychiatr, vol. 85, no. 1, pp. 17-33, 2017.
2016
M. C. van Maaren, de Munck, L., de Bock, G. H., Jobsen, J. J., van Dalen, T., Linn, S. C., Poortmans, P., Strobbe, L. J. A., and Siesling, S., 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study., Lancet Oncol, vol. 17, no. 8, pp. 1158-1170, 2016.
M. Fulks, Dolan, V. F., and Stout, R. L., 2014 CRL Build Study of Life Insurance Applicants., J Insur Med, vol. 46, no. 1, pp. 13-9, 2016.
S. A. Freitas, MacKenzie, R., Wylde, D. N., Roudebush, B. T., Bergstrom, R. L., J Holowaty, C., Hart, A., Rigatti, S. J., and Gill, S. J., All-Cause Mortality for Diabetics or Individuals with Hyperglycemia Applying for Life Insurance., J Insur Med, vol. 46, no. 1, pp. 2-12, 2016.
M. Dörmann, [Assessment of prescriptive therapies and remedies - Experience and results]., Versicherungsmedizin, vol. 68, no. 4, pp. 176-9, 2016.
M. C. van Maaren, Poortmans, P., and Siesling, S., Breast-conserving therapy versus mastectomy., Oncoscience, vol. 3, no. 11-12, pp. 304-305, 2016.
M. C. van Maaren, de Munck, L., Jobsen, J. J., Poortmans, P., de Bock, G. H., Siesling, S., and Strobbe, L. J. A., Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients., Breast Cancer Res Treat, vol. 160, no. 3, pp. 511-521, 2016.
C. O. Jacke and Wild, F., [Can we transfer the mechanisms of the generics market to biosimilars?], Versicherungsmedizin, vol. 68, no. 4, pp. 168-72, 2016.

Pages

Subscribe to Syndicate